Literature DB >> 934725

Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy.

P R Huttenlocher.   

Abstract

Metabolic effects of a new ketogenic regimen in which ketonemia is induced by feeding of medium chain triglycerides (MCT) are described, and comparisons are made with effects of the standard high fat ketogenic diet. Eighteen children maintained on the MCT diet for 3 months to 4 years failed to show elevations of serum cholesterol and had only a slight rise in serum total fatty acids, in contrast to the marked hyperlipidemia observed in children on the standard high fat diet. Long term use of the MCT diet did not affect pH of venous blood. Blood glucose fell below 50 mg/100 ml in one-third of the children, the lowest levels being reached 2--3 weeks after the start of the diet. Plasma D(--)-beta-hydroxybutyrate (BHB) and acetoacetate rose gradually after institution of diet therapy, maximum levels being reached after about 1 month. Higher levels of BHB and acetoacetate were achieved in children under the age of 10 years (BHB = 4.3 mM +/- 0.6 SEM, acetoacetate = 1.8 mM +/- 0.3 SEM) than in 10--18 year olds (BHB = 1.6 mM +/- 0.2 SEM, acetoacetate = 0.57 mM +/- 0.08 SEM). Plasma BHB and acetoacetate levels in children maintained on a 3:1 high fat diet were similar to those in children on a 60% MCT diet. Plasma levels of BHB showed a significant correlation with anticonvulsant effect (P less than 0.02). Both the ketonemia and the anticonvulsant action were reversed rapidly by intravenous infusion of glucose.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 934725     DOI: 10.1203/00006450-197605000-00006

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  79 in total

Review 1.  Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.

Authors:  Heather M Wilkins; Russell H Swerdlow
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 2.  Astrocytic regulation of glutamate homeostasis in epilepsy.

Authors:  Douglas A Coulter; Tore Eid
Journal:  Glia       Date:  2012-05-16       Impact factor: 7.452

3.  Purines and the Anti-Epileptic Actions of Ketogenic Diets.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin; Jeremy Gawryluk; Xuesong Chen; Jonathan D Geiger
Journal:  Open Neurosci J       Date:  2010-01-01

4.  Dietary approaches to epilepsy treatment: old and new options on the menu.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

Review 5.  Neuroprotective and disease-modifying effects of the ketogenic diet.

Authors:  Maciej Gasior; Michael A Rogawski; Adam L Hartman
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

6.  Glycolytic inhibition by 2-deoxy-d-glucose abolishes both neuronal and network bursts in an in vitro seizure model.

Authors:  Li-Rong Shao; Carl E Stafstrom
Journal:  J Neurophysiol       Date:  2017-04-12       Impact factor: 2.714

7.  Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models.

Authors:  Carl E Stafstrom; Jeffrey C Ockuly; Lauren Murphree; Matthew T Valley; Avtar Roopra; Thomas P Sutula
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 8.  The ketogenic diet: metabolic influences on brain excitability and epilepsy.

Authors:  Andrew Lutas; Gary Yellen
Journal:  Trends Neurosci       Date:  2012-12-08       Impact factor: 13.837

9.  The ketogenic diet: uses in epilepsy and other neurologic illnesses.

Authors:  Kristin W Barañano; Adam L Hartman
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

10.  Ketogenic diets and thermal pain: dissociation of hypoalgesia, elevated ketones, and lowered glucose in rats.

Authors:  David N Ruskin; Tracey A C S Suter; Jessica L Ross; Susan A Masino
Journal:  J Pain       Date:  2013-03-15       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.